ESC-like Cell Generation via Adult Stem Cell Coculture
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for obtaining embryonic stem cells require embryos or gametes, leading to ethical concerns and limitations in developing immune reaction-free patient-specific therapies.
Innovation Solution
A method for preparing embryonic stem cell-like cells from mammalian tissue or body fluids without using embryos or gametes, involving coculturing adult stem cells with somatic cells in a medium containing leukemia inhibitory factor to induce pluripotency.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If embryonic stem cells are obtained using conventional methods (embryos or gametes), then pluripotent stem cells can be generated, but ethical concerns and limitations in developing immune reaction-free patient-specific therapies arise
Solution Approach 1:
The patent creates ESC-like cells that copy the essential properties of embryonic stem cells (pluripotency, self-renewal capability, expression of stem cell markers) without using actual embryos or gametes. Adult stem cells are reprogrammed to mimic embryonic stem cell characteristics, thereby achieving the therapeutic benefits while avoiding ethical and immunological issues
Solution Approach 2:
The patent changes the biological parameters of adult stem cells through coculture with embryonic fibroblasts and exposure to specific culture conditions (leukemia inhibitory factor, serum replacement). This reprogramming transforms differentiated adult cells into pluripotent ESC-like cells, altering their developmental potential and molecular characteristics without requiring embryos
2Ease of manufacture
If adult stem cells are cocultured with embryonic fibroblasts in a medium containing leukemia inhibitory factor, then pluripotent ESC-like cells can be generated without embryos or gametes, but the culture process and conditions become more complex
Solution Approach 1:
The patent uses embryonic fibroblasts as intermediary cells to facilitate the reprogramming of adult stem cells. The fibroblasts provide a supportive microenvironment and secrete factors that induce pluripotency in the adult stem cells during coculture, acting as a biological mediator in the transformation process
Solution Approach 2:
The patent maintains continuous coculture of adult stem cells with embryonic fibroblasts in a optimized medium containing leukemia inhibitory factor and serum replacement over an extended period. This continuous culture condition sustains the reprogramming process and allows gradual acquisition of pluripotent characteristics without interrupting the transformation
Data Source
AI summary
Disclosed is a method for preparing an embryonic stem cell (ESC)-like cell, which includes the steps of: (a) obtaining a first cell population from a mammalian tissue or body fluid, wherein the first cell population comprises adult stem cells; (b) obtaining a second somatic cell population from a mammalian tissue, wherein the mammalian tissue is different from the mammalian tissue in step (a) and the second cell population is different from the first cell population; (c) coculturing the first cell population and the second cell population in a medium for a period of time sufficient to form a colony from either the first cell population or the second cell population; and (d) subculturing a cell from the colony in a medium for a period time sufficient to prepare the ESC-like cell.